TIS tissue therapies limited

cap raising: massive dilute for retail holders

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    From my first brush reading,look like a massive dilution for existing long term retail holders, in favour of the larger holders. Coupled with this, they get the opportunity to grab even more because their new shares will participate in the rights issue (which surprise, isnt underwritten).

    Thanks Dr Mercer. Please hit me harder...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.